MedPath

Efficacy of flax seed oil in treating mild to moderate psoriasis vulgaris comparing with topical Bethamethasonel

Not Applicable
Conditions
PSORIASIS VULGARIS PLAQUE TYPE.
Psoriasis vulgaris
L40.0
Registration Number
IRCT20191211045692N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Type of psoriasis vulgaris disease with mild to moderate plaque type
- Not to suffer underlying diseases disrupting the therapy, such as obesity, pregnancy, dialysis, AIDS, psychotic disorder, thyroid and parathyroid T d iseases
Not to use medicines affecting psoriasis disease, such as Beta-blocker, lithium, anti-malaria, corticosteroids and systemic steroids, calcium channel blockers, interleukin
Confirmation of clinical diagnosis by a dermatologist

Exclusion Criteria

- Suffering each of the abovementioned diseases or confirming the diagnosis of any disease, interfering with the treatment, and mentioned in the inclusion criteria, in any moment of the treatment cycle
- Patient dissatisfaction with going on the treatment
Any physical and chemical trauma and surgery, which inevitably makes the patient involved, and leads to the disease exacerbation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Erythem. Timepoint: At First and End of One Month. Method of measurement: PASI QUESTIONARE.;Scaling. Timepoint: At First and End of One Month. Method of measurement: PASI QUESTIONARE.;Induration. Timepoint: At First and End of One Month. Method of measurement: PASI QUESTIONARE.;Area. Timepoint: At First and End of One Month. Method of measurement: PASI QUESTIONARE.;PASI Score. Timepoint: At First and End of One Month. Method of measurement: PASI QUESTIONARE.;QUALITY OF LIFE. Timepoint: FIRST AND ONE MONTH LATER. Method of measurement: DLQ QUESTIONNARE.;SATICFACTION. Timepoint: FIRST AND ONE MONTH LATER. Method of measurement: SATISFACTION QUESTION.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath